| GSBGX | VSCPX | GSBGX / VSCPX | |
| Total Expense Ratio | 0.67 | 0.02 | 3,350% |
| Annual Report Gross Expense Ratio | 0.72 | 0.02 | 3,600% |
| Fund Existence | 4 years | 16 years | - |
| Gain YTD | 9.734 | 18.865 | 52% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 300000000 | 100000000 | 300% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 731M | 183B | 0% |
| Annual Yield % from dividends | 0.11 | 1.24 | 9% |
| Returns for 1 year | 12.26 | 27.73 | 44% |
| Returns for 3 years | 6.29 | 52.04 | 12% |
| Returns for 5 years | N/A | 39.30 | - |
| Returns for 10 years | N/A | 160.91 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYBOX | 74.67 | 1.67 | +2.29% |
| Rydex Biotechnology A | |||
| WSMNX | 28.54 | 0.59 | +2.11% |
| William Blair Small-Mid Cap Growth N | |||
| HSCCX | 3.26 | 0.03 | +0.93% |
| Carillon Eagle Small Cap Growth C | |||
| MCLRX | 18.39 | 0.16 | +0.88% |
| BlackRock Advantage Large Cap Core Inv C | |||
| TRZBX | 223.77 | 1.80 | +0.81% |
| T. Rowe Price Blue Chip Growth Z | |||